Using genome-wide mapping in the mouse to identify genes that influence drug response
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (2) , 55-58
- https://doi.org/10.1016/s0165-6147(02)00044-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in miceHuman Molecular Genetics, 2002
- Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in ɑ4 and ɑ6 nicotinic receptor genesPharmacogenetics, 2002
- Quantitative trait loci influencing morphine antinociception in four mapping populationsMammalian Genome, 2001
- Strain differences in haematological response to chloroamphenicol succinate in mice: implications for toxicological researchFood and Chemical Toxicology, 2001
- Applications of Genetically Manipulated Mice in Pharmacogenetics and PharmacogenomicsPharmacology, 2000
- Pharmacogenetics and the practice of medicineNature, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- Prospects for whole-genome linkage disequilibrium mapping of common disease genesNature Genetics, 1999
- Experimental strategies for the genetic dissection of complex traits in animal modelsNature Genetics, 1998
- Increased basal expression of hepatic Cyp1a1 and Cyp 1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicityPharmacogenetics, 1997